Product
rFVIII
1 clinical trial
1 indication
Indication
Von Willebrand DiseaseClinical trial
A Phase 3b, Prospective, Open-Label, Uncontrolled, Multicenter Study on Long-Term Safety and Efficacy of rVWF in Pediatric and Adult Subjects With Severe Von Willebrand Disease (VWD)Status: Recruiting, Estimated PCD: 2025-03-31